July 27, 2017 6:09 PM ET

Biotechnology

Company Overview of Alexion Pharmaceuticals, Inc.

Key Executives for Alexion Pharmaceuticals, Inc.

NameBoard RelationshipsTitleAge
Ludwig N. Hantson Ph.D.28 RelationshipsChief Executive Officer & Director54
David John Anderson MBA23 RelationshipsCFO & Executive VP68
Julie O'Neill MBA38 RelationshipsExecutive Vice President of Global Operations61
Daniel A. Bazarko CPANo RelationshipsChief Accounting Officer and Senior Vice President--
Indrani M. Lall Franchini J.D.No RelationshipsExecutive VP and Chief Compliance Officer--
View More Key Executives

Alexion Pharmaceuticals, Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
David R. Brennan 16 RelationshipsAlexion Pharmaceuticals, Inc.63
Ludwig N. Hantson Ph.D. 28 RelationshipsAlexion Pharmaceuticals, Inc.54
Andreas Rummelt Ph.D. 36 RelationshipsInterPharmaLink AG61
Ann M. Veneman J.D. 56 RelationshipsAlexion Pharmaceuticals, Inc.68
John T. Mollen 9 RelationshipsAlexion Pharmaceuticals, Inc.66
View All Board Members

Alexion Pharmaceuticals, Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee Christopher J. Coughlin41 Relationships4 Executives
Compensation Committee John T. Mollen9 Relationships4 Executives
Nominating Committee J.D.Ann M. Veneman56 Relationships6 Executives
Corporate Governance Committee J.D.Ann M. Veneman56 Relationships6 Executives
Finance Committee Christopher J. Coughlin41 Relationships4 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

CEO COMPENSATION IN THIS INDUSTRY

  Industry Range
Salary
392.3K
Bonus
240.1K
Total Short Term Compensation
487.6K
Total Value of Options
18.5M
Compensation as of Fiscal Year
Alexion Pharmaceuticals, Inc. CEO Compensation
Industry Average

INDUSTRY EXECUTIVE CHANGES

Adocia Appoints Stanislav Glezer as Chief Medical Officer
July 26, 2017 4:00 PM ET
PharmaCyte Biotech, Inc. Appoints Linda S. Sher as its Chief Medical Officer
July 26, 2017 1:00 PM ET
Kiadis Pharma N.V Appoints Otto Schwarz as Supervisory Board Member
July 26, 2017 5:00 AM ET
Abeona Therapeutics Inc. Names Juan Ruiz as Chief Medical Officer
July 25, 2017 12:05 PM ET
Intellia Therapeutics Inc. Announces Executive Changes
July 24, 2017 10:30 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Alexion Pharmaceuticals, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.